NCT07139769 Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer
| NCT ID | NCT07139769 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zeba Ahmad, Ph.D. |
| Condition | Caregiving for Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-10-22 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-10-22 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP (E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYAs with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.
Eligibility Criteria
Inclusion Criteria: * Self-identifying parent/guardian who provides a primary informal caregiving role in their child's cancer * Recipient of caregiving is aged between 15 and 39 years and is receiving treatment for cancer at the Mass General Brigham Cancer * Participant must score equal to or greater than 2 (out of a possible 10) on the National Comprehensive Cancer Network Distress Thermometer * English-speaking * Aged over 18 years Exclusion Criteria: -Active symptoms of psychosis or suicidal ideation that would preclude safe participation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07139769 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Caregiving for Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07139769 currently recruiting?
Yes, NCT07139769 is actively recruiting participants. Contact the research team at zahmad2@mgh.harvard.edu for enrollment information.
Where is the NCT07139769 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07139769 clinical trial?
NCT07139769 is sponsored by Zeba Ahmad, Ph.D.. The trial plans to enroll 48 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.